New CFO puts a Spring in Veracyte's step
This article was originally published in Scrip
Veracyte, a molecular diagnostics company working on molecular cytology, has appointed Mark Spring chief financial officer. Mr Spring previously served as vice-president and CFO for Prometheus Laboratories before it was bought by Nestle in 2011. Prior to that, he served as vice-president and CFO at Hyperion Therapeutics.